USP30Beyond's analysis on USP302026-09-10 — Vincere Biosciences secures $2.7 million NIH funding to progress its USP30 inhibitor for acute kidney injury treatmentRecent news mentioning USP302026-09-10 — Vincere Biosciences Awarded $2.7 Million NIH Grant to Advance USP30 Inhibitor for Acute Kidney InjuryAppears alongsideNIHBrowse the full archive →